The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZambeef Prod. Regulatory News (ZAM)

Share Price Information for Zambeef Prod. (ZAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.75
Bid: 5.50
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 0.50 (9.091%)
Open: 5.75
High: 5.75
Low: 5.75
Prev. Close: 5.75
ZAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

30 Sep 2016 07:00

RNS Number : 2572L
Zambeef Products PLC
30 September 2016
 

30 September 2016

Zambeef Products plc

("Zambeef" or "the Group")

Year End Trading Update

Zambeef (AIM: ZAM), the fully integrated agribusiness with operations in Zambia, Nigeria and Ghana, is pleased to provide an update on its performance for the year ending 30 September 2016. The audited annual results are expected to be announced on 25 November 2016.

Group Overview

The strong trading performance of the first six months of the financial year has continued with the beef, pork, dairy and stock feed operations, in particular, all showing strong volume growth. This is largely due to the ongoing roll-out of the macro retail stores.

 

The conclusion of the CDC Group plc transaction (as initially announced on 4 August 2016) resulted in an investment into Zambeef of US$65.0 million. This enabled Zambeef to settle the two RCL Foods plc put options as well as substantially reduce the Group's indebtedness. This is in line with Zambeef's strategy of unlocking value within the Group whilst minimising shareholder dilution and reducing debt and gearing.

 

During the second half of the financial year, the Zambian Kwacha has continued to remain relatively stable against the US Dollar, and the Group is expected to incur foreign exchange gains for the financial year.

 

In view of this, the Group expects US Dollar reported profits for the year to 30 September 2016 to be materially higher than current market expectations.

 

Carl Irwin, Joint Chief Executive of Zambeef, commented:

"In line with the Group's strategy, it is pleasing to note that gearing has been reduced significantly following the CDC transaction, which also allowed Zambeef to settle the two RCL Foods plc put options. Furthermore, driving the cold chain food products through the retail network will continue to be a key focus."

 

For further information, please contact:

 

Zambeef Products plc

Carl Irwin, Joint Chief Executive Officer

Francis Grogan, Joint Chief Executive Officer

 

Tel: +260 (0) 211 369003

Strand Hanson Limited

James Spinney

Frederick Twist

Ritchie Balmer

 

Tel: +44 (0) 20 7409 3494

Finncap

Joanna Scott

Christopher Raggett

 

Tel: +44 (0) 20 7220 0500

Powerscourt

Nick Dibden

Nick Brown

 

Tel: +44 (0) 20 7250 1446

Pangaea Securities

Ceaser Siwale

Wendy Tembo 

 

Tel: +260 (0) 211 220 707

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

About Zambeef Products Plc

Zambeef Products Plc is the largest integrated agribusiness and food processor in Zambia, involved in the primary production, processing, distribution and retailing of beef, chickens, pork, milk, eggs, dairy products, fish, flour and stock feed throughout Zambia. The Group has one of the largest cereal row cropping operations in Africa, with a total of 24,174 hectares planted during FY2015. The group is also in the process of rolling out its West Africa expansion in Nigeria and Ghana.

 

The Group has approximately 6,200 employees.

 

Further information can be found on www.zambeefplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEUFIUFMSEIU
Date   Source Headline
23rd Apr 20242:30 pmRNSTrading Update
9th Apr 20248:00 amRNSDirectorate Change
28th Mar 20247:00 amRNSNotice of Death of Chairman
3rd Jan 20249:30 amRNSResult of AGM
8th Dec 20238:00 amRNSPosting of Annual Report and Notice of AGM
7th Dec 20239:00 amRNSFull Year Results
4th Dec 20238:09 amRNSTrading Statement
7th Nov 20232:00 pmRNSFull Year Trading Update
18th Oct 20235:35 pmRNSHolding(s) in Company
21st Sep 202311:39 amRNSGroup Restructuring
30th Jun 20237:00 amRNSHalf-year Results
21st Jun 202310:00 amRNSDirectorate Change
9th Jun 20238:00 amRNSTrading Statement
7th Jun 20238:00 amRNSTrading Update
21st Apr 20231:00 pmRNSDirectorate Change
5th Dec 20223:00 pmRNSFull Year Results
1st Dec 202212:00 pmRNSDirectorate Change
30th Nov 20228:00 amRNSTrading Statement
22nd Nov 202210:00 amRNSDirectorate Change
10th Nov 20223:00 pmRNSTrading Update
18th Jul 20228:30 amRNSInternational Finance Corporation Funding
29th Jun 20221:30 pmRNSChange of Chief Executive Officer
27th Jun 20222:05 pmRNSSecond Price Monitoring Extn
27th Jun 20222:00 pmRNSPrice Monitoring Extension
16th Jun 20224:41 pmRNSSecond Price Monitoring Extn
16th Jun 20224:35 pmRNSPrice Monitoring Extension
16th Jun 20222:06 pmRNSSecond Price Monitoring Extn
16th Jun 20222:00 pmRNSPrice Monitoring Extension
16th Jun 202211:05 amRNSSecond Price Monitoring Extn
16th Jun 202211:00 amRNSPrice Monitoring Extension
16th Jun 20229:30 amRNSUSD100m Investment Strategy
15th Jun 20223:30 pmRNSInterim Results
31st May 20228:00 amRNSTrading Statement
30th May 202210:00 amRNSDirectorate Change
27th Apr 20221:00 pmRNSHalf Year Trading Update
14th Apr 20221:00 pmRNSDirectorate Change
22nd Mar 20222:28 pmRNSHolding(s) in Company
21st Dec 20212:00 pmRNSResult of AGM and Appointment of External Auditor
30th Nov 20219:00 amRNSFull Year Results
19th Nov 202112:37 pmRNSAMENDED: Trading Statement
18th Nov 20218:00 amRNSTrading Statement
21st Oct 20212:00 pmRNSYear End Trading Update
13th Jul 20219:09 amRNSHolding(s) in Company
29th Jun 20218:29 amRNSDirector/PDMR Shareholding
11th Jun 202111:30 amRNSHalf-year Report
4th Jun 20212:59 pmRNSHolding(s) in Company
3rd Jun 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSHalf Year Trading Update
10th Mar 202111:21 amRNSChange of Adviser and Directorate Changes
26th Feb 20217:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.